Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more
Respiratory
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
Nubilaria provides free EDC for pro bono COVID-19 related ARDS study
Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read more
Altasciences completes Gimsilumab Phase I study for ARDS in COVID-19
Canadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19
Read more
EU waiving VAT and customs duty on critical medical devices
The European Commission has waived customs duty and VAT on medical devices imported from non-EU countries. A decision has been
Read more
Roche’s Actemra (tocilizumab) shows “excellent effects” against COVID-19
The widely used arthritis medicine Actemra (tocilizumab) has demonstrated “excellent effects” in the treatment of the COVID-19 disease. Roche’s promising
Read more
FDA grants Emergency Use Authorisation for Roche’s Coronavirus Test
Roche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read more
Ganovo and Ritonavir combo success in COVID-19 Clinical Trial
Ascletis Pharma’s investigational Ganovo and Ritonavir combo-therapy shows promise in COVID-19 Clinical Trial. Chinese biotech Ascletis Pharma Inc. (HKEX code:
Read more